Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gary L Davis

Showing results (11-20 of 67) with videos related to

Pageof 7
Sort By:
Nutrition in Clinical Practice : Official Publication of the American Society for Parenteral and Enteral Nutrition|June 15, 2006
Thoughts on nutrition and liver diseaseGary L Davis
Clinics in Liver Disease|December 14, 2006
New therapies: oral inhibitors and immune modulatorsGary L Davis
Clinical Liver Disease|April 18, 2019
New AASLD/IDSA hepatitis C virus practice recommendations: An online resourceGary L Davis
Cleveland Clinic Journal of Medicine|October 8, 2004
The evolving treatment of chronic hepatitis C: where we stand a decade outSherif Saadeh, Gary L Davis
Reviews in Gastroenterological Disorders|December 8, 2004
Management of ascites in patients with end-stage liver diseaseSherif Saadeh, Gary L Davis
Therapeutic Advances in Gastroenterology|December 25, 2010
Hepatitis C virus replication and potential targets for direct-acting agentsJacqueline G O'Leary, Gary L Davis
Reviews in Gastroenterological Disorders|July 19, 2002
Best of the AASLD. Highlights from the 52nd Annual Meeting of the American Association for the Study of Liver Diseases. November 9-13, 2001, Dallas, TXEmmet B Keeffe, Gary L Davis
Current Gastroenterology Reports|March 6, 2014
Impact of birth cohort screening for hepatitis CSumeet K Asrani, Gary L Davis
Clinical Liver Disease|June 13, 2019
Demographics of hepatitis C virus todayStevan A Gonzalez, Gary L Davis
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|October 1, 2009
Conivaptan increases serum sodium in hyponatremic patients with end-stage liver diseaseJacqueline G O'Leary, Gary L Davis
Pageof 7

Showing results (11-20 of 67) with videos related to

Sort By:
Pageof 7
Nutrition in Clinical Practice : Official Publication of the American Society for Parenteral and Enteral Nutrition|June 15, 2006
Thoughts on nutrition and liver diseaseGary L Davis
Clinics in Liver Disease|December 14, 2006
New therapies: oral inhibitors and immune modulatorsGary L Davis
Clinical Liver Disease|April 18, 2019
New AASLD/IDSA hepatitis C virus practice recommendations: An online resourceGary L Davis
Cleveland Clinic Journal of Medicine|October 8, 2004
The evolving treatment of chronic hepatitis C: where we stand a decade outSherif Saadeh, Gary L Davis
Reviews in Gastroenterological Disorders|December 8, 2004
Management of ascites in patients with end-stage liver diseaseSherif Saadeh, Gary L Davis
Therapeutic Advances in Gastroenterology|December 25, 2010
Hepatitis C virus replication and potential targets for direct-acting agentsJacqueline G O'Leary, Gary L Davis
Reviews in Gastroenterological Disorders|July 19, 2002
Best of the AASLD. Highlights from the 52nd Annual Meeting of the American Association for the Study of Liver Diseases. November 9-13, 2001, Dallas, TXEmmet B Keeffe, Gary L Davis
Current Gastroenterology Reports|March 6, 2014
Impact of birth cohort screening for hepatitis CSumeet K Asrani, Gary L Davis
Clinical Liver Disease|June 13, 2019
Demographics of hepatitis C virus todayStevan A Gonzalez, Gary L Davis
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|October 1, 2009
Conivaptan increases serum sodium in hyponatremic patients with end-stage liver diseaseJacqueline G O'Leary, Gary L Davis
Pageof 7